ArticleThe NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects
-
Add time:08/26/2019 Source:sciencedirect.com
Antagonism of the NMDA receptor with MK-801 is considered to be an effective pharmacologic manipulation to prevent the development of sensitization effects to drugs such as cocaine. The present study investigated this issue by comparing the behavioral response of separate groups of rats to three treatment cycles of either saline, 0.1 mg/kg MK-801, 10 mg/kg cocaine, or combined MK-801-cocaine (0.110 mg/kg). The treatments were spaced 1 week apart and were preceded by two nondrug baseline tests. In the first test cycle, the four groups had equivalent activity levels in the two nondrug tests. In the first drug test only the MK-801-cocaine group exhibited hyperactivity. By the third drug test, the MK-801-cocaine group exhibited an enhanced hyperactivity and the MK-801 group became hyperactive. Thus, behavioral drug sensitization developed but only with groups treated with MK-801. Antagonism of the NMDA receptor under some circumstances can be a highly effective treatment for the induction of behavioral sensitization effects.
We also recommend Trading Suppliers and Manufacturers of MK 287 (cas 135947-75-0). Pls Click Website Link as below: cas 135947-75-0 suppliers
Prev:Original articleBupivacaine-induced convulsion is suppressed by MK-801
Next:Effects of MK-801 and antidepressant drugs in the forced swimming test in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regional brain catecholamines and metabolites following THC, PCP and MK-80108/28/2019
- Effects of MK-801 and antidepressant drugs in the forced swimming test in rats08/27/2019
- Original articleBupivacaine-induced convulsion is suppressed by MK-80108/25/2019
- A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)08/24/2019
- Research PapersStandardization and Identification of Minor Components of Silymarin (MK-001)08/23/2019
- Research PaperCardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats08/22/2019
- On-Chip ESR Measurements of DPPH at mK Temperatures☆08/21/2019
- Synthesis and biological activity of MK 287 (cas 135947-75-0) (L-680,573): a potent, specific and orally active paf receptor antagonist08/20/2019
- Enantioselective synthesis of the PAF antagonist MK-28708/19/2019


